TEVA PHARMACEUTICAL INDUSTRIES LIMITED Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability Value
TEVA PHARMACEUTICAL INDUSTRIES LIMITED (TEVJF) had Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability Value of $49.00 million as of 2026-06-30, per its 10-Q filed 2026-07-29.
Financial Statements › Notes › Fair Value Disclosures
us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue · last filed 2026-07-29
- 2026-06-30: Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability Value $49.00M.
- 2026-03-31: Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability Value $40.00M.
- 2025-12-31: Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability Value $51.00M.
- 2025-09-30: Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability Value $198.00M.
| Period end | Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability Value | Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability Value as first filed |
|---|---|---|
| 2026-06-30 | $49.00M 10-Q · filed 2026-07-29 | |
| 2026-03-31 | $40.00M 10-Q · filed 2026-04-29 | |
| 2025-12-31 | $51.00M 10-Q · filed 2026-07-29 | |
| 2025-09-30 | $198.00M 10-Q · filed 2025-11-05 | |
| 2025-06-30 | $303.00M 10-Q · filed 2026-07-29 | |
| 2025-03-31 | $394.00M 10-Q · filed 2026-04-29 | |
| 2024-12-31 | $401.00M 10-Q · filed 2026-07-29 | |
| 2024-09-30 | $552.00M 10-Q · filed 2025-11-05 | |
| 2024-06-30 | $616.00M 10-Q · filed 2025-07-30 | |
| 2024-03-31 | $527.00M 10-Q · filed 2025-05-07 | |
| 2023-12-31 | $477.00M 10-K · filed 2026-02-03 | |
| 2023-09-30 | $159.00M 10-Q · filed 2024-11-06 | $28.00M 10-Q · filed 2023-11-09 |
| 2023-06-30 | $264.00M 10-Q · filed 2024-07-31 | $142.00M 10-Q · filed 2023-08-02 |
| 2023-03-31 | $261.00M 10-Q · filed 2024-05-08 | $148.00M 10-Q · filed 2023-05-10 |
| 2022-12-31 | $250.00M 10-K · filed 2025-02-05 | $152.00M 10-K · filed 2023-02-10 |
| 2022-09-30 | $112.00M 10-Q · filed 2023-11-09 | |
| 2022-06-30 | $204.00M 10-Q · filed 2023-08-02 | |
| 2022-03-31 | $196.00M 10-Q · filed 2023-05-10 | |
| 2021-12-31 | $175.00M 10-K · filed 2024-02-12 | |
| 2021-09-30 | $186.00M 10-Q · filed 2022-11-03 | |
| 2021-06-30 | $204.00M 10-Q · filed 2022-07-27 | |
| 2021-03-31 | $245.00M 10-Q · filed 2022-05-03 | |
| 2020-12-31 | $258.00M 10-K · filed 2023-02-10 | |
| 2020-09-30 | -$27.00M 10-Q · filed 2021-10-27 | $27.00M 10-Q · filed 2020-11-05 |
| 2020-06-30 | $471.00M 10-Q · filed 2021-07-28 | |
| 2020-03-31 | $423.00M 10-Q · filed 2021-04-28 | |
| 2019-12-31 | $448.00M 10-K · filed 2022-02-09 | |
| 2019-09-30 | $418.00M 10-Q · filed 2019-11-07 | |
| 2019-06-30 | $390.00M 10-Q · filed 2019-08-07 | |
| 2019-03-31 | $392.00M 10-Q · filed 2019-05-02 | |
| 2018-12-31 | $497.00M 10-K · filed 2021-02-10 | |
| 2018-09-30 | $699.00M 10-Q · filed 2018-11-01 | |
| 2018-06-30 | $703.00M 10-Q · filed 2018-08-02 | |
| 2017-12-31 | $717.00M 10-K · filed 2020-02-21 | |
| 2016-12-31 | $811.00M 10-K · filed 2019-02-19 | |
| 2015-12-31 | -$811.00M 20-F · filed 2016-02-11 | |
| 2014-12-31 | -$616.00M 20-F · filed 2016-02-11 | |
| 2013-12-31 | -$347.00M 20-F · filed 2016-02-11 |